Background: There is an unmet need for a single-stage cartilage repair treatment that is cost-effective and chondrocyte-based.
Purpose: To evaluate the safety and preliminary efficacy of autologous freshly isolated primary chondrocytes and bone marrow mononucleated cells (MNCs) seeded into a PolyActive scaffold in patients with symptomatic cartilage lesions of the knee.
Study Design: Case series; Level of evidence, 4.